Skip to content

To study the effect of Talahridaya Marma chikitsa and sarpaghandha ghan vati in the management of Prehypertension

An Anatomical study of Talahridaya Marma and Role of Talahridaya Marma Chikitsa and Sarpaghandha Ghan Vati in the Management of Prehypertension :A Randomised Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077734
Enrollment
60
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

National Institute of Ayurveda ,Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient lying within the age group of 21-50 years Patient is currently not taking any drugs for hypertension Patient will come under the prehypertension range 120-139 mm of Hg systolic BP to 80-89mm of Hg diastolic BP

Exclusion criteria

Exclusion criteria: Patient who are suffering from acute systemic disease Pregant lady,lactating mothers and females who have recent history of abortion Patient coming under the range of grade 1 and grade 2 hypertension

Design outcomes

Primary

MeasureTime frame
Change in JNC criteriaTimepoint: 30 days

Secondary

MeasureTime frame
Improvement in the patient conditionTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Sunil Kumar Yadav

National Institute of ayurveda,Jaipur

drskyadav4@gmail.com9413181445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026